AI in China: Global Health Lessons for Medical Tech

China's expanding use of artificial intelligence in healthcare echoes historical global health discussions on balancing innovation, safety, and public trust. Christoph Benn, a veteran in international health cooperation, views this as a continuation of established global trajectories rather than a new phenomenon.

Benn stresses that realizing AI's benefits in healthcare necessitates responsible application, guided by clear standards and public trust. He notes that governance tools forged through past global health challenges like pandemics are directly applicable to medical AI oversight.

International experience provides China with a framework for embedding technology within robust evaluation and correction institutions. Benn advocates for each nation to possess the capacity to assess and certify AI tools, ensuring this capability isn't restricted to wealthy countries.

China's approach, encompassing national plans and pilot programs, reflects an understanding that technology alone isn't transformative. Benn likens these efforts to earlier global health governance discussions, highlighting the need for development in AI oversight to match technological advancement.

China's large-scale medical AI implementation, including AI-assisted diagnostics and remote surgery, offers significant real-world laboratory insights. This experience is particularly relevant for Global South countries, potentially enabling advancements where even basic digital infrastructure was previously lacking.

While acknowledging the risk of AI exacerbating health inequalities, Benn asserts that proactive design can ensure low-income settings benefit. He concludes that international cooperation, through shared standards and technology transfer, is essential to prevent advanced AI from being confined to affluent areas, underscoring that global challenges demand collaborative solutions.